CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The project aims to develop a vaccine against invasive non-typhoidal Salmonellosis, a significant health issue in sub-Saharan Africa. It utilizes a novel vaccine technology and plans to conduct clinical trials to assess safety and immune response.
Invasive non-typhoidal Salmonellosis (iNTS) is an important emerging Neglected Infectious Disease in resource-poor settings of sub-Saharan Africa (sSA).
No vaccine is currently available.
Estimated 263,000 iNTS deaths per year in <5 year olds, a 20% case fatality rate, difficult diagnosis and increasing antibiotic resistance strongly advocate for rapid development of an effective vaccine.
Vacc-iNTS bridges the gap between preclinical and early clinical development of a novel vaccine against iNTS…
SCLAVO VACCINES ASSOCIATION
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Fondazione Achille Sclavo ONLUS
Italy, Siena
Type: Research institute
Activity type: Research Organisations
SME: No
Belgium, Rixensart
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
GSK VACCINES INSTITUTE FOR GLOBAL HEALTH SRL
Italy, Siena
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
United Kingdom, Oxford
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
